Literature DB >> 10581197

In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes.

J Chevalier1, J M Pagès, M Malléa.   

Abstract

Cephalosporins are widely used in chemotherapy of bacterial infections and resistance mechanisms seriously impair their antibacterial activity. Several resistant strains of Enterobacter aerogenes, a frequently isolated nosocomial pathogen, were analyzed. One isolate exhibited a strong modification of the porin antigenic pattern, especially with an immunological probe directed against an epitope located inside the pore lumen. A strong decrease of cefepime uptake was evidenced for this isolate, similarly to ones observed for porin-deficient strains: these kinetics show a serious alteration of the channel properties which may support cephalosporin resistance. This is the first E. aerogenes isolate using such adaptive response which defines an original enterobacterial answer to cephalosporin. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581197     DOI: 10.1006/bbrc.1999.1795

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region.

Authors:  Jérôme Bredin; Nathalie Saint; Monique Malléa; Emmanuelle Dé; Gérard Molle; Jean-Marie Pagès; Valérie Simonet
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

2.  Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains.

Authors:  Stéphane Gayet; Renaud Chollet; Gérard Molle; Jean-Marie Pagès; Jacqueline Chevalier
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 3.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

4.  Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.

Authors:  Aurélie Thiolas; Claude Bollet; Bernard La Scola; Didier Raoult; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Interaction of zwitterionic penicillins with the OmpF channel facilitates their translocation.

Authors:  Christophe Danelon; Ekaterina M Nestorovich; Mathias Winterhalter; Matteo Ceccarelli; Sergey M Bezrukov
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

6.  Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.

Authors:  Hesna Yigit; Gregory J Anderson; James W Biddle; Christine D Steward; J Kamile Rasheed; Lourdes L Valera; John E McGowan; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae.

Authors:  J Chevalier; M Malléa; J M Pagès
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

Review 8.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

9.  Colicins, spermine and cephalosporins: a competitive interaction with the OmpF eyelet.

Authors:  Jérôme Bredin; Valérie Simonet; Ramkumar Iyer; Anne H Delcour; Jean-Marie Pagès
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

10.  Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae.

Authors:  Melanie Olesky; Marcia Hobbs; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.